Skip to main content
. 2020 Nov 5;21(12):1097–1104. doi: 10.1080/15384047.2020.1834319

Figure 3.

Figure 3.

Potential mechanisms associated with HPD induced by immunotherapy. In addition to PI3K/AKT pathway, several genetic alterations and clinical factors have been stated to be involved in HPD, which including mouse double minute 2 (MDM2) or MDM4 amplification, alteration of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK). The potential cell signaling pathways contributed to HPD were displayed